ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
GlycoMimetics Inc

GlycoMimetics Inc (GLYC)

0.2723
0.0025
(0.93%)
Cerrado 27 Enero 3:00PM
0.2795
0.0072
(2.64%)
Fuera de horario: 6:18PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.2795
Postura de Compra
0.265
Postura de Venta
0.2796
Volume Operado de la Acción
231,423
0.26 Rango del Día 0.2744
0.1406 Rango de 52 semanas 3.5242
Capitalización de Mercado [m]
Precio Anterior
0.2698
Precio de Apertura
0.265
Última hora de negociación
Volumen financiero
US$ 62,039
Precio Promedio Ponderado
0.268076
Volumen promedio (3 m)
1,161,766
Acciones en circulación
64,483,958
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.47
Beneficio por acción (BPA)
-0.57
turnover
10k
Beneficio neto
-36.9M

Acerca de GlycoMimetics Inc

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Wilmington, Delaware, USA
Fundado
-
GlycoMimetics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLYC. The last closing price for GlycoMimetics was US$0.27. Over the last year, GlycoMimetics shares have traded in a share price range of US$ 0.1406 to US$ 3.5242.

GlycoMimetics currently has 64,483,958 shares in issue. The market capitalisation of GlycoMimetics is US$17.40 million. GlycoMimetics has a price to earnings ratio (PE ratio) of -0.47.

GLYC Últimas noticias

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024 Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1...

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.026510.47430830040.2530.280.251670470.25995921CS
40.01997.66563944530.25960.29920.23164116990.2593245CS
12-0.13-31.7460317460.40950.44770.191211617660.33727423CS
26-0.0255-8.36065573770.3050.630.1406104646140.46313692CS
52-3.2205-92.01428571433.53.52420.140664736530.48298012CS
156-0.8205-74.59090909091.14.160.140624026420.64174304CS
260-4.4305-94.06581740984.715.750.140616724650.97251472CS

GLYC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de GlycoMimetics?
El precio actual de las acciones de GlycoMimetics es US$ 0.2795
¿Cuántas acciones de GlycoMimetics están en circulación?
GlycoMimetics tiene 64,483,958 acciones en circulación
¿Cuál es la capitalización de mercado de GlycoMimetics?
La capitalización de mercado de GlycoMimetics es USD 17.4M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de GlycoMimetics?
GlycoMimetics ha negociado en un rango de US$ 0.1406 a US$ 3.5242 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de GlycoMimetics?
El ratio precio/beneficio de GlycoMimetics es -0.47
¿Cuál es el ratio de efectivo a ventas de GlycoMimetics?
El ratio de efectivo a ventas de GlycoMimetics es 1.35k
¿Cuál es la moneda de reporte de GlycoMimetics?
GlycoMimetics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de GlycoMimetics?
El último ingresos anual de GlycoMimetics es USD 10k
¿Cuál es el último beneficio anual de GlycoMimetics?
El último beneficio anual de GlycoMimetics es USD -36.9M
¿Cuál es la dirección registrada de GlycoMimetics?
La dirección registrada de GlycoMimetics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de GlycoMimetics?
La dirección del sitio web de GlycoMimetics es www.glycomimetics.com
¿En qué sector industrial opera GlycoMimetics?
GlycoMimetics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

GLYC Discussion

Ver más
Spending4fun Spending4fun 2 meses hace
Tomorrow November 19th, GLYC will be presenting thier developments at the London Healthcare conference. Hopefully this results into this stock shooting up. 🚀🚀
👍️0
BurgerKing82 BurgerKing82 3 meses hace
Looks interesting
👍️0
BurgerKing82 BurgerKing82 3 meses hace
Looks interesting
👍️0
TechandBio TechandBio 3 meses hace
GLYC Sold at .60 yesterday for 203% profit.

Next micro cap buyout or hostile take over will be BFRI interesting price action after hours FDA approved drug for AK skin cancer with late stage pipeline for Basil Cell and Squamous cell carcinoma Phase 3 and Acne Phase 2 call your dermatologist I bet they use Ameluz
the FDA also just green lighted 3 tubes can be used in a single session from 1 $400 a tube =$1200

https://www.biofrontera-us.com/research/product-pipeline

https://www.investing.com/news/company-news/biofrontera-locks-phase-3-sbcc-study-database-for-analysis-93CH-3662035


https://us.ameluz.com/
$GLYC
👍️ 1
INV4 INV4 3 meses hace
Bought some more GLYC this morning.

================

Biotech Up Over +100% Premarket Following Merger And Funding Announcement

Tuesday, October 29, 2024

A Maryland-based biotech company is already dominating Tuesday’s session prior to the opening bell after it was announced that the company will be merging with Crescent Biopharma and that it secured approximately $200 million in funding to financing operations through 2027, according to this morning’s release.

Traders were quick to snatch up shares of GlycoMimetics Inc. (Nasdaq:GLYC), with the current bid sitting at $0.3694/share (+119.62% implied open for sellers) at the time of writing. It should be an exciting session for this micro cap!

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

https://www.allpennystocks.com/specialreportsus/3692/biotech-up-over-100-premarket-following-merger-and-funding-announcement?utm_source=advfn

$GLYC
👍️0
dennisv dennisv 3 meses hace
Renewed Opportunities!
👍️ 1
hondaboost hondaboost 3 meses hace
My tons of GLYC shares at $0.17 now have Huge gains!!! Go, go, go!!!!!
👍️ 1
dennisv dennisv 3 meses hace
Higher Peaks!
👍️ 1
dennisv dennisv 3 meses hace
There is a lot of room.
Let's do it!
👍️0
tw0122 tw0122 3 meses hace
Up 200% 09:44 AM EDT, 10/29/2024 (MT Newswires) -- GlycoMimetics' (GLYC) shares climbed by more than 125% early Tuesday after saying it has agreed to be acquired by Crescent Biopharma, a privately held biotechnology company advancing a pipeline of oncology therapeutics.
👍️ 1
glenn1919 glenn1919 3 meses hace
glyc....................................https://stockcharts.com/h-sc/ui?s=glyc&p=W&b=5&g=0&id=p86431144783
👍️ 1
Sierra20 Sierra20 7 meses hace
Bankruptcy proceedings next. You been warned. Check out my latest post.
👍️0
hondaboost hondaboost 7 meses hace
GLYC was $3.5 in Jan. Institutions and mutual funds holding 50 million shares at dollars, out of 64 million OS.
👍️ 1
hondaboost hondaboost 7 meses hace
GLYC, Chief Medical Officer bought 310,000 shares at $0.26 at open market on June 21. He must know something.


https://www.otcmarkets.com/filing/html?id=17638385&guid=RXO-kWK48IECJth
👍️0
Invest-in-America Invest-in-America 7 meses hace
GLYC: Article here ---
https://www.defenseworld.net/2024/06/25/glycomimetics-inc-nasdaqglyc-insider-edwin-rock-buys-190000-shares.html#google_vignette
👍️0
TheFinalCD TheFinalCD 7 meses hace
you usually post the bottom charts before they go
👍️0
tw0122 tw0122 7 meses hace
Hitting .43s looking good
👍️0
Sierra20 Sierra20 7 meses hace
Delisting letter coming. You have been warned.
👍️0
glenn1919 glenn1919 7 meses hace
GLYC............................https://stockcharts.com/h-sc/ui?s=GLYC&p=W&b=5&g=0&id=p86431144783
👍️0
subslover subslover 7 meses hace
Nice insider buys here = https://www.otcmarkets.com/filing/html?id=17638385&guid=NwO-kFXCNX90B3h
👍️0
Monksdream Monksdream 9 meses hace
GLYC new low
👍️0
spindog spindog 9 meses hace
Well? Good thing i held off on taking a position….
👍️0
Monksdream Monksdream 9 meses hace
Gotta wait it out
👍️0
spindog spindog 9 meses hace
Hopefully the FDA will give GLYC the the green light after reviewing phase 3 data in June
👍️0
Monksdream Monksdream 9 meses hace
GLYC under $2
👍️0
Monksdream Monksdream 10 meses hace
GLYC under $4
👍️0
willlbone willlbone 2 años hace
Dilution.
👍️0
INFINITI INFINITI 2 años hace
Reversal
👍️0
TechandBio TechandBio 2 años hace
Picked up a few heavy racks of shares under 2.95 today.


$GLYC
👍️0
Invest-in-America Invest-in-America 2 años hace
GLYC: Hey!!!! WHAT???? (HA-HA!!)
👍️0
makinezmoney makinezmoney 2 años hace
$GLYC: The chart is screaming bullflag breakout on 100day chart

Now at 2.50


Perfect BULL FLAG.


NICE


GO $GLYC
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 2 años hace
$GLYC Crazy runner here..on watch to see if it continues as insider bought a ton of shares..

https://stocktwits.com/soll/message/497100283

https://stockcharts.com/c-sc/sc?s=GLYC&p=D&b=5&g=0&i=0&r=1668953354914
👍️0
Invest-in-America Invest-in-America 2 años hace
THANKS!
👍️0
gail gail 2 años hace
yup and congrats on your other runner.
👍️0
Invest-in-America Invest-in-America 2 años hace
GO-GO-GO-GLYC!!!

PS: Hey, Girl, tap my latest POSTS behind @GRND --- what a SPECTACLE that one is!!!! (I grabbed their WARRANTS!!)

👍️0
gail gail 2 años hace
looking good here.
👍️0
gail gail 2 años hace
wow, new highs hitting right now!
👍️0
gail gail 2 años hace
and back to 2 bucks. lets see what tomorrow brings.
👍️0
gail gail 2 años hace
boing, and back up she goes.
👍️0
gail gail 2 años hace
manipulation bringing it …

..

down but lets see what happens.
👍️0
gail gail 2 años hace
here we go, breaking 2 bucks big time now.
👍️0
gail gail 2 años hace
its time to break 2 bucks and really move like it did in the past.
👍️0
1hot toddy 1hot toddy 2 años hace
WOW WOW WOW CHIEF MEDICAL OFFICIER BOUGHT 200,000 SHARES $$$

he went from 0 shares to 200000 in two days. 2- 100000 shares buys 2 days

now 4 employees have bought shares.
👍️0
1hot toddy 1hot toddy 2 años hace
WOOOOOOOOOOOOOOOOOW 63000 SHARE BUY $$$$$$$$$$$$$$$$

employees are buying toooooooooo
👍️0
1hot toddy 1hot toddy 2 años hace
3 HUGE INSIDE BUYS BY 3 PEOPLE. 19K, 20K AND 25K $$$$$$$$$$$$$$$$

1.06/1.29 UP UP AND AWAY
👍️0
willlbone willlbone 3 años hace
Back to 99 cents.
👍️0
MfridgeV2 MfridgeV2 4 años hace
Agreed. Things looking up. Load up while no one else wants it. ;)
👍️0
fishhunter fishhunter 4 años hace
Now is but time. The gap has filled, weak hands are out, corporate path is correct.
👍️0
mining101 mining101 4 años hace
Depends at what level - if back to 2s first it’s a big loss till then
👍️0
stockguard stockguard 4 años hace
The Investment Case For GlycoMimetics
https://seekingalpha.com/article/4389595-investment-case-for-glycomimetics
👍️0

Su Consulta Reciente

Delayed Upgrade Clock